212 related articles for article (PubMed ID: 37330511)
1. Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation.
Wang Z; Xie K; Zhu G; Ma C; Cheng C; Li Y; Xiao X; Li C; Tang J; Wang H; Su Z; Liu D; Zhang W; Huang Y; Tang H; Liu R; Li W
Respir Res; 2023 Jun; 24(1):163. PubMed ID: 37330511
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
[No Abstract] [Full Text] [Related]
3. Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning.
Liang N; Li B; Jia Z; Wang C; Wu P; Zheng T; Wang Y; Qiu F; Wu Y; Su J; Xu J; Xu F; Chu H; Fang S; Yang X; Wu C; Cao Z; Cao L; Bing Z; Liu H; Li L; Huang C; Qin Y; Cui Y; Han-Zhang H; Xiang J; Liu H; Guo X; Li S; Zhao H; Zhang Z
Nat Biomed Eng; 2021 Jun; 5(6):586-599. PubMed ID: 34131323
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA.
Wu H; Guo S; Liu X; Li Y; Su Z; He Q; Liu X; Zhang Z; Yu L; Shi X; Gao S; Wang H; Pan Y; Ma C; Liu R; Dai M; Jin G; Liang Z
BMC Med; 2022 Nov; 20(1):458. PubMed ID: 36434648
[TBL] [Abstract][Full Text] [Related]
5. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer.
Gao Y; Zhao H; An K; Liu Z; Hai L; Li R; Zhou Y; Zhao W; Jia Y; Wu N; Li L; Ying J; Wang J; Xu B; Wu Z; Tong Z; He J; Sun Y
Clin Transl Med; 2022 Aug; 12(8):e1014. PubMed ID: 35998020
[TBL] [Abstract][Full Text] [Related]
8. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
9. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
10. Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA.
Peng M; Xie Y; Li X; Qian Y; Tu X; Yao X; Cheng F; Xu F; Kong D; He B; Liu C; Cao F; Yang H; Yu F; Xu C; Tian G
J Med Genet; 2019 Oct; 56(10):647-653. PubMed ID: 30981987
[TBL] [Abstract][Full Text] [Related]
11. Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy.
Jin S; Zhu D; Shao F; Chen S; Guo Y; Li K; Wang Y; Ding R; Gao L; Ma W; Lu T; Li D; Zhang Z; Cai S; Liang X; Song H; Ji L; Li J; Zheng Z; Jiang F; Wu X; Luan J; Zhang H; Yang Z; Cantor CR; Xu C; Ding C
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495330
[TBL] [Abstract][Full Text] [Related]
12. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
[TBL] [Abstract][Full Text] [Related]
13. Detection of non-metastatic non-small-cell lung cancer in urine by methylation-specific PCR analysis: A feasibility study.
Wever BMM; Bach S; Tibbesma M; Ter Braak TJ; Wajon D; Dickhoff C; Lissenberg-Witte BI; Hulbert A; Kazemier G; Bahce I; Steenbergen RDM
Lung Cancer; 2022 Aug; 170():156-164. PubMed ID: 35793574
[TBL] [Abstract][Full Text] [Related]
14. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.
Shields MD; Chen K; Dutcher G; Patel I; Pellini B
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012272
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer.
Zhang B; Niu X; Zhang Q; Wang C; Liu B; Yue D; Li C; Giaccone G; Li S; Gao L; Zhang H; Wang J; Yang H; Wu R; Ni P; Wang C; Ye M; Liu W
Lung Cancer; 2019 Aug; 134():108-116. PubMed ID: 31319968
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study.
Kang G; Chen K; Yang F; Chuai S; Zhao H; Zhang K; Li B; Zhang Z; Wang J
BMC Cancer; 2019 Jun; 19(1):579. PubMed ID: 31195991
[TBL] [Abstract][Full Text] [Related]
17. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW
Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642
[TBL] [Abstract][Full Text] [Related]
18. Circulating epigenetic biomarkers for detection of recurrent colorectal cancer.
Symonds EL; Pedersen SK; Murray D; Byrne SE; Roy A; Karapetis C; Hollington P; Rabbitt P; Jones FS; LaPointe L; Segelov E; Young GP
Cancer; 2020 Apr; 126(7):1460-1469. PubMed ID: 31909823
[TBL] [Abstract][Full Text] [Related]
19. Evaluating personalized circulating tumor DNA detection for early-stage lung cancer.
Huang H; Kai Z; Wang Y; Zhang X; Wang J; Zhang W; Xue Q; Zhang H; Jin H; Meng P; Zhang S; Yang Y; Yang H; Liang W; Zha G; Luo P; Xu Y; Shi W; Ruan Z
Cancer Med; 2024 May; 13(10):e6817. PubMed ID: 38112031
[TBL] [Abstract][Full Text] [Related]
20. RNF213 gene mutation in circulating tumor DNA detected by targeted next-generation sequencing in the assisted discrimination of early-stage lung cancer from pulmonary nodules.
Jiang N; Zhou J; Zhang W; Li P; Liu Y; Shi H; Zhang C; Wang Y; Zhou C; Peng C; Zhang W; Hao Y; Sun Q; Li Y; Zhao X
Thorac Cancer; 2021 Jan; 12(2):181-193. PubMed ID: 33200540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]